ArticleCardio-oncology (London, England)2025

QT STAR: concomitant QTc-prolonging medication use among patients with HR+/HER2- metastatic breast cancer receiving a CDK4/6 inhibitor in first line.

Susan Dent et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.